Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gorlin's Syndrome”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Testing effectiveness (Phase 2)WithdrawnNCT03767439
What this trial is testing

Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome

Who this might be right for
Basal Cell Nevus Syndrome
Columbia University
Testing effectiveness (Phase 2)Study completedNCT00961896
What this trial is testing

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Who this might be right for
Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
Novartis Pharmaceuticals 18
Early research (Phase 1)Study completedNCT00433485
What this trial is testing

Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

Who this might be right for
Neoplastic SyndromeNon-melanomatous Skin Cancer
Yale University 16
Large-scale testing (Phase 3)Study completedNCT06050122
What this trial is testing

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Who this might be right for
Gorlin Syndrome
Sol-Gel Technologies, Ltd. 113
Testing effectiveness (Phase 2)Study completedNCT01556009
What this trial is testing

Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas

Who this might be right for
Basal Cell Nevus SyndromeGorlin's Syndrome
UCSF Benioff Children's Hospital Oakland 24
Not applicableStudy completedNCT00555633
What this trial is testing

Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients

Who this might be right for
Skin CancerXeroderma PigmentosumBasal Cell Nevus Syndrome
Medical University of Graz 13
Not applicableLooking for participantsNCT03050268
What this trial is testing

Familial Investigations of Childhood Cancer Predisposition

Who this might be right for
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
St. Jude Children's Research Hospital 1,500
Testing effectiveness (Phase 2)Study completedNCT00783965
What this trial is testing

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

Who this might be right for
Skin Carcinoma
UCSF Benioff Children's Hospital Oakland 34
Testing effectiveness (Phase 2)Ended earlyNCT02002689
What this trial is testing

LDE225 for Patients With PTCH1 or SMO Mutated Tumors

Who this might be right for
PTCH1 or SMO Activated Solid and Hematologic Tumors
Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Study completedNCT02550678
What this trial is testing

The Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma

Who this might be right for
Basal Cell Nevus SyndromeSkin NeoplasmNodular Basal Cell Carcinoma of Skin
Ascend Biopharmaceuticals Ltd 16
Early research (Phase 1)Looking for participantsNCT06623201
What this trial is testing

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma (BCC)
Nathalie Zeitouni 20
Not applicableEnrolling By InvitationNCT06330324
What this trial is testing

Reproductive Options in Inherited Skin Diseases

Who this might be right for
IchthyosisPalmoplantar KeratosesEpidermolysis Bullosa+7 more
Maastricht University Medical Center 650
Not applicableStudy completedNCT00005660
What this trial is testing

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

Who this might be right for
Basal Cell CarcinomaKeratosis Palmaris et PlantarisPsoriasis
National Cancer Institute (NCI) 130
Large-scale testing (Phase 3)Study completedNCT03703310
What this trial is testing

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Who this might be right for
Basal Cell Nevus Syndrome
Sol-Gel Technologies, Ltd. 174
Not applicableLooking for participantsNCT05463757
What this trial is testing

Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

Who this might be right for
Basal Cell CarcinomaLocally Advanced Basal Cell CarcinomaMetastatic Basal Cell Carcinoma+8 more
Maastricht University Medical Center 80
Not applicableLooking for participantsNCT06330350
What this trial is testing

Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling

Who this might be right for
Quality of LifeIchthyosisPalmoplantar Keratoses+7 more
Maastricht University Medical Center 25
Not applicableLooking for participantsNCT04569149
What this trial is testing

Primordial Dwarfism Registry

Who this might be right for
MOPDIIMeier-Gorlin SyndromeSaul-Wilson Syndrome+4 more
Nemours Children's Clinic 200
Early research (Phase 1)Study completedNCT03467789
What this trial is testing

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

Who this might be right for
Basal Cell CarcinomaBasal Cell Nevus Syndrome
Case Comprehensive Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00023621
What this trial is testing

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Who this might be right for
Non-melanomatous Skin Cancer
University of California, San Francisco 60
Testing effectiveness (Phase 2)Study completedNCT01350115
What this trial is testing

Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Who this might be right for
Basal Cell CarcinomaGorlin SyndromeNevoid Basal Cell Carcinoma Syndrome
Novartis Pharmaceuticals 10
Next Page